Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	392.71	633.91	128.66
Graham Fair Price	-1.34	0.29	0.29
PEG	-61.57	2.48	-6.47
Price/Book	-1.33	1.09	1.11
Price/Cash Flow	673.36	-102.73	13.28
Prices/Earnings	-11.23	-516.07	581.35
Price/Sales	11.37	3.58	3.21
Price/FCF	673.36	-102.73	13.28
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-5.51	0.09	0.09
Operating Margin	71.41	< 0.005	< 0.005
ROA	12.68	< 0.005	< 0.005
ROE	< 0.005	< 0.005	11.15
ROIC	< 0.005	< 0.005	111.95
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.03	-0.02	28.80
Dividends QOQ	0.15	-0.29	95.24
EBIT QOQ	-1.22	2.50	105.27
EPS QOQ	-0.90	-2.08	-130.97
FCF QOQ	3.03	-1.13	-62.84
Revenue QOQ	0.09	-0.12	45.52
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	59.94	68.71	14.62
Days Sales Outstanding (DSO)	123.25	128.51	4.27
Inventory Turnover	1.50	1.31	-12.75
Debt/Capitalization	0.44	0.45	2.09
Quick Ratio	0.65	0.63	-2.82
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	2.83	2.65	-6.42
Cash	0.72	0.66	-8.63
Capex	0.07	-0.06	-23.06
Free Cash Flow	0.24	-0.03	-88.06
Revenue	0.97	0.81	-17.09
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.84	0.84	-0.96
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	41.85	217.30	419.28
Naive Interpretation	Member

06 - Financial Health · Bad

Rating